Assignee
ALBITAR MAHER
US·11 granted patents·5 pending applications·52 citations·filing 2006–2012
Top patents by PatentIndex Score
16 records- 0193US8093063B2Assay for detecting genetic abnormalities in genomic nucleic acidsALBITAR MAHER·Filed 2007·Granted Jan 10, 2012·17 cites·48 claims
- 0290US8114618B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysALBITAR MAHER·Filed 2011·Granted Feb 14, 2012·9 cites·16 claims
- 0389US8501423B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysALBITAR MAHER·Filed 2012·Granted Aug 6, 2013·7 cites·6 claims
- 0488US8512948B2Compositions and methods for detecting mutations in JAK2 nucleic acidALBITAR MAHER·Filed 2010·Granted Aug 20, 2013·4 cites·9 claims
- 0588US8232068B2Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assaysALBITAR MAHER·Filed 2012·Granted Jul 31, 2012·7 cites·13 claims
- 0685US9488656B2BCR-ABL truncation mutationsALBITAR MAHER·Filed 2010·Granted Nov 8, 2016·4 cites·22 claims
- 0781US9702877B2BCR-ABL variantsALBITAR MAHER·Filed 2009·Granted Jul 11, 2017·4 cites·18 claims
- 0860US8097468B2Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignanciesALBITAR MAHER·Filed 2009·Granted Jan 17, 2012·0 cites·4 claims
- 0959US2010099084A1Detection of npm1 nucleic acid in acellular body fluidsALBITAR MAHER·Filed 2008·Application pending·0 cites
- 1057US9255926B2Hematopoietic cell phenotyping using circulating cell-free markersALBITAR MAHER·Filed 2006·Granted Feb 9, 2016·0 cites·4 claims
- 1156US8563323B2Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignanciesALBITAR MAHER·Filed 2011·Granted Oct 22, 2013·0 cites·7 claims
- 1254US2013288236A1Wt1 mutations for prognosis of myeloproliferative disordersALBITAR MAHER·Filed 2010·Application pending·0 cites
- 1351US2009123920A1Jak2 mutationsALBITAR MAHER·Filed 2007·Application pending·0 cites
- 1448US2008118940A1Proteasomal peptidase activity and the use thereof in clinical applicationsALBITAR MAHER·Filed 2007·Application pending·0 cites
- 1544US8124351B2Quantification of fusion proteins and their activity from chromosomal translocationALBITAR MAHER·Filed 2006·Granted Feb 28, 2012·0 cites·18 claims
- 1644US2007248961A1Methods for detecting mutations in JAK2 nucleic acidALBITAR MAHER·Filed 2006·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →